EUNICE JORDAN: Open Payments
NPI 1104345420 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,055 in 95 payments from 11 companies in 2025. Trend: 2023 $1,008 · 2024 $887 · 2025 $1,055
Food & beverage: $1,007Education: $47
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $302 |
| Vanda Pharmaceuticals Inc. | 17 | $195 |
| Alkermes, Inc. | 16 | $184 |
| Lundbeck LLC | 20 | $172 |
| E.R. Squibb & Sons, L.L.C. | 4 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Tris Pharma Inc | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: VRAYLAR, FANAPT, REXULTI, ARISTADA, COBENFY, CAPLYTA, ABILIFY MAINTENA, LYBALVI.
Industry payments across IN — which companies pay providers there.
